Dana-Farber Scientists to Showcase Over 50 Research Studies at AACR Annual Meeting 2026
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research ...
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research ...
In a significant leap forward for the management of a perplexing blood cancer precursor, researchers at Dana-Farber Cancer Institute in ...
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial, ...
In a groundbreaking advancement in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking advancement poised to revolutionize acute leukemia diagnosis and treatment, researchers at the Dana-Farber Cancer Institute have unveiled ...
A groundbreaking new analysis from Dana-Farber Cancer Institute highlights a significant link between diet, physical activity, and survival outcomes in ...
A groundbreaking clinical study spearheaded by researchers at the Dana-Farber Cancer Institute in Boston is embarking on an innovative quest ...
Nurses have always played a pivotal role in the healthcare system, especially in oncology, where they serve not just as ...
In an extraordinary advancement for the field of genetics, researchers associated with the Dana-Farber Cancer Institute have unveiled a groundbreaking ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine